Knight Therapeutics Inc
(GUD.TO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 514,942 | 389,402 | 363,713 | 204,785 | 237,481 |
| Marketable Securities | 272,897 | 289,845 | 311,473 | 252,672 | 257,314 |
| Receivables | 10,498 | 8,995 | 4,651 | 3,180 | 2,802 |
| Inventories | 790 | 785 | 833 | 1,339 | 1,460 |
| TOTAL | $799,752 | $689,027 | $680,670 | $461,976 | $499,480 |
| Non-Current Assets | |||||
| PPE Net | 32 | N/A | 0 | 10 | 18 |
| Investments And Advances | 170,756 | 178,187 | 176,469 | 167,950 | 143,643 |
| Intangibles | 14,153 | 6,276 | 5,956 | 6,079 | 3,320 |
| Other Non-Current Assets | 6,077 | 4,414 | 4,904 | 2,321 | 2,527 |
| TOTAL | $191,018 | $188,877 | $187,329 | $176,360 | $149,508 |
| Total Assets | $990,770 | $877,904 | $867,999 | $638,336 | $648,988 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 748 | 1,870 | 1,289 | 1,294 | 39 |
| Accrued Expenses | 2,459 | N/A | N/A | N/A | 2,377 |
| TOTAL | $9,758 | $7,826 | $6,034 | $5,663 | $6,740 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 355 | 369 | 0 | 151 | 293 |
| Other Non-Current Liabilities | 877 | 0 | 0 | 0 | 0 |
| TOTAL | $1,294 | $479 | $0 | $0 | $186 |
| Total Liabilities | $11,052 | $8,305 | $6,034 | $5,663 | $6,926 |
| Shareholders' Equity | |||||
| Common Shares | 760,447 | 664,561 | 662,702 | 439,176 | 439,148 |
| Retained earnings | 178,586 | 170,647 | 164,949 | 160,503 | 160,026 |
| Other shareholders' equity | 31,216 | 25,914 | 26,602 | 25,149 | 36,116 |
| TOTAL | $979,718 | $869,599 | $861,965 | $632,673 | $642,062 |
| Total Liabilities And Equity | $990,770 | $877,904 | $867,999 | $638,336 | $648,988 |